Prostate Cancer Trial, Recruiting NCT04797039 Sponsor: Mayo Clinic Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT04797039
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

"Who might be able to join this trial:

  • People who have been diagnosed with Gleason 7 prostate cancer confirmed by a biopsy, and have been referred to a specialist for treatment
  • People for whom surgery or radiation therapy is not considered a suitable treatment option at the time of joining the trial
  • People whose tumor is smaller than 2 cm at its widest point
  • People whose tumor has not spread into the rectal wall or the muscle that controls urination (the external urethral sphincter)
  • People who are able to have an MRI scan

Who may not be able to join:

  • No formal exclusion criteria were listed in the official trial record (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying."

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 507-255-0111

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
1 December 2020
Est. completion
1 December 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Technical success of the MR-guided cryoablation; Safety of the MR-guided cryoablation; Examine short term tumor recurrence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov